Neill Iscoe

1.2k total citations
24 papers, 564 citations indexed

About

Neill Iscoe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Neill Iscoe has authored 24 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Neill Iscoe's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (7 papers). Neill Iscoe is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (7 papers). Neill Iscoe collaborates with scholars based in Canada, United States and Netherlands. Neill Iscoe's co-authors include Harriette J. Kahn, Lynn From, Jennifer Ramsay, Shailendra Verma, Suresh Senan, Ian Quirt, Kate Bak, Manya Charette, David R. McCready and Everett E. Vokes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Neill Iscoe

24 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neill Iscoe Canada	13	316	204	136	124	80	24	564
Mitsunori Higuchi Japan	14	275 0.9×	250 1.2×	126 0.9×	170 1.4×	85 1.1×	77	654
Ainara Soria Spain	12	336 1.1×	133 0.7×	121 0.9×	134 1.1×	46 0.6×	46	505
Carla M. van Herpen Netherlands	14	325 1.0×	146 0.7×	195 1.4×	113 0.9×	98 1.2×	27	608
Neysa Garner United States	2	392 1.2×	102 0.5×	103 0.8×	210 1.7×	33 0.4×	2	529
WP Peters United States	11	467 1.5×	71 0.3×	102 0.8×	152 1.2×	36 0.5×	24	827
Philippe C. Bishop United States	12	166 0.5×	100 0.5×	110 0.8×	66 0.5×	49 0.6×	17	499
Wojciech Rogowski Poland	12	286 0.9×	180 0.9×	204 1.5×	80 0.6×	79 1.0×	40	650
Jean‐Marc Tourani France	13	334 1.1×	121 0.6×	134 1.0×	62 0.5×	83 1.0×	29	696
Thomas Grellety France	12	399 1.3×	274 1.3×	113 0.8×	149 1.2×	48 0.6×	42	613
Olav Erich Yri Norway	10	218 0.7×	112 0.5×	58 0.4×	119 1.0×	31 0.4×	22	484

Countries citing papers authored by Neill Iscoe

Since Specialization

Citations

This map shows the geographic impact of Neill Iscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neill Iscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neill Iscoe more than expected).

Fields of papers citing papers by Neill Iscoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neill Iscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neill Iscoe. The network helps show where Neill Iscoe may publish in the future.

Co-authorship network of co-authors of Neill Iscoe

This figure shows the co-authorship network connecting the top 25 collaborators of Neill Iscoe. A scholar is included among the top collaborators of Neill Iscoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neill Iscoe. Neill Iscoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brade, Anthony, Frederik Wenz, Friederike Koppe, et al.. (2018). Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 101(4). 927–934. 25 indexed citations

Vokes, Everett E., Ramaswamy Govindan, Neill Iscoe, et al.. (2018). The Impact of Staging by Positron-Emission Tomography on Overall Survival and Progression-Free Survival in Patients With Locally Advanced NSCLC. Journal of Thoracic Oncology. 13(8). 1183–1188. 8 indexed citations

Brade, Anthony, Robert M. MacRae, Scott A. Laurie, et al.. (2015). Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer. Clinical Lung Cancer. 17(2). 133–141. 8 indexed citations

Chiappori, Alberto, Gerold Bepler, Fabrice Barlési, et al.. (2010). Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(3). 369–375. 37 indexed citations

Clemons, Mark, et al.. (2010). Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy. Breast Cancer Research and Treatment. 124(1). 177–186. 15 indexed citations

Brade, Anthony, Andrea Bezjak, Robert M. MacRae, et al.. (2010). Phase I Trial of Radiation With Concurrent and Consolidation Pemetrexed and Cisplatin in Patients With Unresectable Stage IIIA/B Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 79(5). 1395–1401. 28 indexed citations

Vokes, Everett E., Suresh Senan, Joseph Treat, & Neill Iscoe. (2009). PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell Histology. Clinical Lung Cancer. 10(3). 193–198. 37 indexed citations

Dent, Susan, S. Gertler, Shailendra Verma, et al.. (2009). A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 65(3). 557–561. 3 indexed citations

Cullen, Michael, Petr Zatloukal, Sverre Sörenson, et al.. (2007). A3-03: Pemetrexed for the treatment of advanced non-small cell lung cancer (NSCLC): Results from a randomized phase III dose finding trial in patients who progressed following platinum-containing chemotherapy. Journal of Thoracic Oncology. 2(8). S316–S317. 3 indexed citations

10.

Verma, Shailendra, Ian Quirt, David R. McCready, et al.. (2006). Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer. 106(7). 1431–1442. 82 indexed citations

11.

Spaner, David, Igor Astsaturov, Thorsten U. Vogel, et al.. (2006). Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100. Cancer. 106(4). 890–899. 34 indexed citations

12.

Romanus, Dorothy, Neill Iscoe, Carlo DeAngelis, Neil H. Shear, & Thomas R. Einarson. (2004). Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patients. Supportive Care in Cancer. 12(12). 844–851. 8 indexed citations

13.

Astsaturov, Igor, Teresa M. Petrella, Emin Ümit Bağrıaçık, et al.. (2003). Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha2b: implications for cancer vaccines.. PubMed. 9(12). 4347–55. 37 indexed citations

14.

Bondy, Susan J., Neill Iscoe, Deanna M. Rothwell, et al.. (2001). Trends in Hormonal Management of Prostate Cancer:. Medical Care. 39(4). 384–396. 10 indexed citations

15.

Iscoe, Neill, Éduardo Bruera, & Richard Choo. (1999). Prostate cancer: 10. Palliative care.. PubMed. 160(3). 365–71. 6 indexed citations

16.

Mercer, Shawna L., Vivek Goel, Isra Levy, et al.. (1997). Prostate Cancer Screening in the Midst of Controversy: Canadian Men’s Knowledge, Beliefs, Utilization, and Future Intentions. Canadian Journal of Public Health. 88(5). 327–332. 27 indexed citations

17.

Ramsay, Jennifer, Lynn From, Neill Iscoe, & Harriette J. Kahn. (1995). MIB-1 Proliferative Activity Is a Significant Prognostic Factor in Primary Thick Cutaneous Melanomas. Journal of Investigative Dermatology. 105(1). 22–26. 82 indexed citations

18.

Goss, Paul E., Martin E. Blackstein, Neill Iscoe, et al.. (1994). Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer. 73(7). 1971–1979. 62 indexed citations

19.

Iscoe, Neill, Elizabeth A. Eisenhauer, & A. Bodurtha. (1990). Phase II study of trimetrexate in malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group Study. Investigational New Drugs. 8(1). 121–123. 5 indexed citations

20.

Iscoe, Neill, et al.. (1988). Observer error in the characterization of hepatic lesions in patients with neoplastic liver disease. Journal of Clinical Ultrasound. 16(8). 577–579. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact